Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05406336

Machine Learning to Reduce Hypertension Treatment Clinical Inertia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Temple University · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Among individuals with an uncontrolled BP at the current visit, the objective of this study is to compare clinical management of hypertension with and without information from a machine learning algorithm on whether a patient will have uncontrolled blood pressure at their next follow up visit through a case-vignette study.

Detailed description

Among adults with uncontrolled blood pressure (BP) at a clinic visit, clinical inertia is common. Clinical inertia is defined as a failure of providers to initiate or intensify treatment (i.e., adding medication or increasing dosage) when guidelines indicate doing so. Prior studies report that clinicians intensify antihypertensive medication treatment in less than 20% of visits where intensification would have been clinically recommended. Thus, patients who have uncontrolled BP may not receive timely therapy to control their BP. To address this issue, the investigators will use a randomized design to test the hypothesis that clinicians will be more likely to intensify the hypertensive regimen and/or assess nonadherence for patients with uncontrolled BP at the current visit when presented with information that a patient is predicted to have uncontrolled BP at the next visit by a machine learning algorithm.

Conditions

Interventions

TypeNameDescription
OTHERPredicted uncontrolled BP status (yes/no) at follow up visit, derived using a machine learning algorithmThe investigators have created a machine learning algorithm to predict uncontrolled blood pressure (BP) status (yes/no) at a follow up visit among adults with uncontrolled BP at their current visit. The investigators will determine whether adding this information to a vignette describing a patient will increase the likelihood that a clinician will intensify antihypertensive medication treatment.

Timeline

Start date
2025-04-25
Primary completion
2025-05-31
Completion
2025-07-31
First posted
2022-06-06
Last updated
2025-04-10

Source: ClinicalTrials.gov record NCT05406336. Inclusion in this directory is not an endorsement.